India, Brazil Ink MoU to Deepen Regulatory Cooperation in Pharma and Medical Products
India’s CDSCO and Brazil’s ANVISA exchanged MoU in the presence of Prime Minister Narendra Modi and President Luiz Inácio Lula da Silva to strengthen regulatory cooperation in pharmaceuticals and medical products.
ANVISA | 23/02/2026 | By News Bureau
ANVISA Approves Concept Medical's MagicTouch SCB for CAD in Brazil
The approval enables commercial sales in Brazil, strengthening Concept Medical’s global footprint and advancing its mission to deliver safer and more effective treatment alternatives. The company is also undergoing ANVISA’s approval process for its wider DCB and DES portfolio, building on its robust clinical trial foundation.
ANVISA | 16/09/2025 | By Dineshwori | 323
Eris Lifesciences Secures ANVISA Approval for its Manufacturing Unit in Ahmedabad
Eris Lifesciences has received ANVISA approval for a manufacturing unit at its Ahmedabad campus, paving the way for entry into Brazil, South America’s largest pharmaceutical market.
ANVISA | 25/08/2025 | By Mrinmoy Dey | 367
Akums' Haridwar Sterile Facility Receives GMP Certificate from Brazil's ANVISA
Akums Drugs and Pharmaceuticals has announced that its sterile manufacturing plant in Haridwar, Uttarakhand, has been awarded the Good Manufacturing Practice (GMP) certificate from ANVISA, the Brazilian health regulatory agency.
ANVISA | 28/07/2025 | By Dineshwori | 798
Pint Pharma Gets ANVISA Approval of BESREMi for Polycythemia Vera
Polycythemia Vera (PV) is a rare, chronic, debilitating, and potentially fatal myeloproliferative neoplasm, originating from a disease-initiating stem cell in the bone marrow.
ANVISA | 21/03/2025 | By Aishwarya | 532
Dipharma receives GMP certification from Brazilian ANVISA
The Baranzate site (Italy) is the first Dipharma manufacturing facility to receive Anvisa certification<br />
Anvisa | 02/12/2022 | By Sudeep Soparkar | 819
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy